13,896 Views
•
12:02 min
•
October 11, 2013
DOI:
Summary
Automatically generated
Tre saggi, tra cui l'effetto citopatico (CPE) a base di test, analisi dose-risposta e Time-of-Addition (ToA) test sono stati sviluppati, ottimizzati, validati ed utilizzati per identificare nuovi farmaci antivirali contro il virus della Bluetongue (BTV), nonché per determinare il meccanismo d'azione possibile (MOA) per i farmaci antivirali di nuova identificazione.
Related Videos
09:28
Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems
Related Videos
111244 Views
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Related Videos
30072 Views
10:50
Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials
Related Videos
18417 Views
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Related Videos
7768 Views
10:05
Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
Related Videos
15107 Views
09:31
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Related Videos
17642 Views
12:50
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Related Videos
6505 Views
06:59
Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
Related Videos
7289 Views
09:40
Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
Related Videos
7316 Views
08:51
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
Related Videos
12254 Views
Read Article
Cite this Article
Gu, L., Schneller, S. W., Li, Q. Assays for the Identification of Novel Antivirals against Bluetongue Virus. J. Vis. Exp. (80), e50820, doi:10.3791/50820 (2013).
Copy